TY - JOUR T1 - Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis JF - bioRxiv DO - 10.1101/2020.06.27.175679 SP - 2020.06.27.175679 AU - Ruilin Tian AU - Anthony Abarientos AU - Jason Hong AU - Sayed Hadi Hashemi AU - Rui Yan AU - Mike A. Nalls AU - Andrew B. Singleton AU - Ke Xu AU - Faraz Faghri AU - Martin Kampmann Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/07/22/2020.06.27.175679.abstract N2 - Single-cell transcriptomics provide a systematic map of gene expression in different human cell types. The next challenge is to systematically understand cell-type specific gene function. The integration of CRISPR-based functional genomics and stem cell technology enables the scalable interrogation of gene function in differentiated human cells. Here, we present the first genome-wide CRISPR interference and CRISPR activation screens in human neurons. We uncover pathways controlling neuronal response to chronic oxidative stress, which is implicated in neurodegenerative diseases. Unexpectedly, knockdown of the lysosomal protein prosaposin strongly sensitizes neurons, but not other cell types, to oxidative stress by triggering the formation of lipofuscin, a hallmark of aging, which traps iron, generating reactive oxygen species and triggering ferroptosis. We also determine transcriptomic changes in neurons following perturbation of genes linked to neurodegenerative diseases. To enable the systematic comparison of gene function across different human cell types, we establish a data commons named CRISPRbrain.Competing Interest StatementM.K. has filed a patent application related to CRISPRi and CRISPRa screening (PCT/US15/40449) and serves on the Scientific Advisory Board of Engine Biosciences and Casma Therapeutics. ER -